Syringeless injector sales will rise through 2036, driven by injectors at 62.5% of the product type segment in 2026. The market was valued at USD 445.7 million in 2025 and is expected to be worth USD 746.5 million by 2036, creating an incremental opportunity of USD 279.4 million.